Kaplan-Meier survival analyses show that patients with low tumor CDKN3 mRNA levels have both significantly higher overall (Figure 4-F) and recurrence-free (Figure 4G-H) survival probability overtime compared to patients with high CDKN3 levels in all three datasets. Here, CDKN3 is linked to neoplasm.